Top 50 Life Science Startup Investors in China (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Prox Ventures
VC Fund
|
7 | China, United States, United Kingdom | Seed, Series A | Medical, Biotechnology, Health Care | $1.9M–$28M |
|
Qiming Venture Partners
VC Fund
|
6 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5M–$134M |
|
HSG
VC Fund
|
5 | China, United States, Hong Kong | Series A, Series B, Series C | Health Care, Biotechnology, Software | $4.4M–$214M |
|
Hillhouse Investment
VC Fund
|
5 | China, United States, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Software | $2.9M–$220M |
|
Linear Capital
VC Fund
|
5 | China, Singapore, Switzerland | Seed, Angel, Series A | Artificial Intelligence, Software, Manufacturing | $1.4M–$122M |
|
EFung Capital
VC Fund
|
4 | China, United States, India | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $1.4M–$87M |
|
Huagai Capital
VC Fund
|
4 | China, United States, Germany | Series A, Series B, Angel | Health Care, Biotechnology, Medical | $425k–$90M |
|
Baidu Ventures
VC Fund
|
4 | China, United States, Singapore | Series A, Seed, Series B | Artificial Intelligence, Health Care, Biotechnology | $1.4M–$145M |
|
Lenovo Capital and Incubator Group (LCIG)
VC Fund
|
4 | China, Hong Kong, United States | Series A, Seed, Series B | Manufacturing, Artificial Intelligence, Software | $1.5M–$150M |
|
Vinno Capital
VC Fund
|
4 | China, United States | Series A, Series B, Seed | Manufacturing, Semiconductor, Medical | $1.4M–$142M |
|
Hillhouse Ventures
VC Fund
|
3 | China, Singapore, Norway | Series A, Series B, Seed | Manufacturing, Biotechnology, Health Care | $10M–$120M |
|
MiraclePlus
VC Fund
|
3 | China, United States, Singapore | Seed, Angel, Pre-Seed | Artificial Intelligence, Software, Information Technology | |
|
ULTIMA
VC Fund
|
3 | China | Angel, Series A | Hardware, Software, Agriculture | $1.6M–$15M |
|
Northern Light Venture Capital
VC Fund
|
3 | China, United States, South Korea | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $1.3M–$100M |
|
CD Capital
VC Fund
|
3 | China, United States | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.4M–$34M |
|
ZSVC
VC Fund
|
3 | China, United States, India | Series A, Seed, Series B | Manufacturing, Medical, Health Care | $1.4M–$85M |
|
BioVenture
VC Fund
|
3 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $3M–$73M |
|
Dalton Venture
VC Fund
|
3 | China, India, Canada | Seed, Series A, Series B | Health Care, Medical, Biotechnology | $450k–$47M |
|
Legend Capital
VC Fund
|
3 | China, United States, South Korea | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $2.9M–$156M |
|
WuXi AppTec
VC Fund
|
3 | United States, China, Israel | Series A, Series B, Series C | Biotechnology, Pharmaceutical, Health Care | $6M–$130M |
|
Entrepreneurship Relay Group
VC Fund
|
3 | China | Series A, Angel | Manufacturing, Software, Enterprise | $222k–$27M |
|
Tianjin Venture Capital
VC Fund
|
3 | China, United States | Seed, Series A | Manufacturing, Information Technology, Biotechnology | $202k–$31M |
|
CITIC Capital Holdings
VC Fund
|
3 | China, United States, Japan | Series A, Series B, Series C | Manufacturing, Health Care, E-Commerce | $2.8M–$230M |
|
Jinqiu Fund
VC Fund
|
2 | China, United States, Hong Kong | Seed, Series A, Angel | Artificial Intelligence, Robotics, Manufacturing | |
|
Sunz Fund
VC Fund
|
2 | China | Series A, Seed, Series B | Medical, Biotechnology, Health Care | $1.4M–$14M |
|
Tsinghua Capital
VC Fund
|
2 | China, Australia | Seed, Angel, Series A | Manufacturing, Artificial Intelligence, Biotechnology | $425k–$73M |
|
Oriental Fortune Capital
VC Fund
|
2 | China, United States | Series A, Series B, Seed | Software, Manufacturing, Information Technology | $1.4M–$100M |
|
Centregold Capital
VC Fund
|
2 | United States, China, Canada | Seed, Series A, Angel | Medical Device, Internet, Health Care | $567k–$12M |
|
Haitang Fund
VC Fund
|
2 | China | Seed, Series A, Venture - Series Unknown | Manufacturing, Biotechnology, Medical | $213k–$44M |
|
Lucion
VC Fund
|
2 | China | Series A, Series B | Biotechnology, Manufacturing, Medical | $1.4M–$539M |
|
Innoangel Fund
VC Fund
|
2 | China, Canada, Hong Kong | Angel, Seed, Series A | Artificial Intelligence, Robotics, Manufacturing | $425k–$27M |
|
Shangshi Fund
VC Fund
|
2 | China | Series A, Angel, Seed | Information Technology, Manufacturing, Artificial Intelligence | $283k–$73M |
|
Huimei Capital
VC Fund
|
2 | China, United States, Japan | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $10M–$227M |
|
BMC
VC Fund
|
2 | China | Seed, Series B | Biotechnology, Medical, Product Research | $1.4M–$14M |
|
Jan Hammer
Angel
|
2 | China, United States, Czech Republic | Series A, Series B, Seed | Health Care, Medical, Medical Device | |
|
Yida China Holdings
VC Fund
|
2 | China, United States | Series A, Series B | Manufacturing, Semiconductor, Biotechnology | |
|
Rivercity Investment
VC Fund
|
2 | China | Seed, Series A, Series C | Medical, Biotechnology, Electronics | |
|
Starlight Capital
VC Fund
|
2 | China | Series A, Series C, Series B | Manufacturing, Robotics, Information Technology | $2M–$55M |
|
CDH Investments
VC Fund
|
2 | China, United States, Canada | Series A, Series B, Series C | Manufacturing, Health Care, Biotechnology | $8.3M–$300M |
|
Danen Capital
VC Fund
|
2 | China, United States | Series A, Angel, Seed | B2B, Fashion, Medical | $1.4M–$6M |
|
Puhua Capital
VC Fund
|
2 | China, United Kingdom, United States | Series A, Series B, Seed | Health Care, Medical, Manufacturing | $1.4M–$103M |
|
Cenova
VC Fund
|
2 | China, Singapore, United States | Series A, Series B, Series C | Medical, Health Care, Biotechnology | $2.8M–$100M |
|
BOHE Angel Fund
VC Fund
|
2 | China | Angel, Seed, Series A | Health Care, Medical, Biotechnology | $1.4M–$100M |
|
Orient Securities Capital Investment
VC Fund
|
2 | China | Series A, Series B, Series D | Manufacturing, Health Care, Software | $1.4M–$100M |
|
Zoo Capital
VC Fund
|
2 | China, United States, Hong Kong | Seed, Series A, Series B | Artificial Intelligence, Biotechnology, Software | $3.2M–$100M |
|
K2VC
VC Fund
|
2 | China, United States, Japan | Series A, Seed, Angel | E-Commerce, Manufacturing, Biotechnology | $425k–$25M |
|
Matrix Partners China
VC Fund
|
2 | China, United States, Singapore | Series A, Series B, Seed | Health Care, Biotechnology, Software | $1.4M–$113M |
|
Eight Roads Ventures
VC Fund
|
2 | United States, China, India | Series B, Series A, Series C | Software, Health Care, Biotechnology | $6.4M–$115M |
|
Loyal Valley Capital
VC Fund
|
2 | China, United States, Hong Kong | Series C, Series A, Series B | Biotechnology, Health Care, Pharmaceutical | $2.7M–$300M |
|
Sherpa Healthcare Partners
VC Fund
|
2 | China, United States, Kenya | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $2.8M–$156M |
| Access all 570 investors in China Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: China, United States, United Kingdom
Investor stats
- Total investments: 79
- Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Shengxin Medical — Shengxin Medical is a cardiovascular interventional medical device developer, dedicated to creating innovative, high-quality solutions that improve the diagnosis, treatment, and management of cardiovascular diseases, while advancing minimally invasive medical technologies to enhance patient outcomes and clinical efficiency.
- Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
- Kingsung Medical Group —
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 803
- Round size: Series A $5M–$68M; Series B $9.4M–$100M; Series C $14M–$134M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $887M in 2023
Portfolio highlights
- Chuman — Chuman is a UGC Pan-Secondary Creation Community, providing creative platforms and studios for comic creators, and providing IP incubation and resource docking services. Users can quickly generate a lot of content through third-party or official materials, and can make friends, transactions and other activities within the community through thecreation, while the APP also supports the dialogue novel reading function.
- Wholee — Wholee is a member-only zero-markup store.
- Zeen Health — Zeen Health is a digital therapeutics company that provides mental health services. Zeen Health was founded in 2019 and was headquartered in Shenzhen, China.
We help founders build enduring companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 751
- Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
- Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
- Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A, Series C
- Geography: China, United States, Singapore
Investor stats
- Total investments: 331
- Round size: Series A $2.9M–$142M; Series B $14M–$219M; Series C $15M–$220M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $11B in 2018
Portfolio highlights
- Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
- Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
- NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Manufacturing
- Stage:Seed, Angel, Series A
- Geography: China, Singapore, Switzerland
Investor stats
- Total investments: 88
- Round size: Seed $1.4M–$122M; Angel $1.4M–$122M; Series A $5.7M–$50M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $500M in 2021
Portfolio highlights
- Pacdora — Pacdora is an incredibly user-friendly online mockup design platform that boasts an extensive collection of 3D mockups and box templates. Whether you're a seasoned designer or just starting out, you can effortlessly create eye-catching mockups in no time. Plus, with our powerful 3D modeling software and a suite of AI design assistant tools atyour fingertips, your creative possibilities are limitless. Unleash your imagination with Pacdora today!
- Rino — L4 autonomous delivery vehicles by Rino.ai serve logistics, retail, and cold chain needs across 100+ cities. Revolutionize your logistics with Autonomous Delivery Vehicles, offering a safe, efficient, and eco-friendly solution for last-mile delivery in urban and rural settings.
- ACXEL Tech — ACXEL Tech develops large area electronics have given us flat panel displays and flexible, wearable devices. ACXEL takes these ‘active’ pixels and puts them to work transporting liquid droplets – precisely and at amazing speed.Millions of pixels are transformed into tiny engines moving samples around via a high throughput, low cost andprogrammable platform, offering a wide range of possibilities in chemistry, biology and medtech.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 74
- Round size: Series A $1.4M–$76M; Series B $14M–$87M; Series C $14M–$74M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Carbonology — Carbonology is a carbon capture company that produces fuels, chemicals, and polyesters.
- Barty Medical — Barty Medical develops, manufactures, and markets coronary drug balloons, peripheral drug balloons, coronary PTCA balloons, peripheral PTA balloons, peripheral drug stents, supporting catheter sheaths, vascular interventional devices, and implanted devices.
- Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Angel
- Geography: China, United States, Germany
Investor stats
- Total investments: 135
- Round size: Angel $425k–$15M; Series A $1.4M–$63M; Series B $3.5M–$90M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $430M in 2018
Portfolio highlights
- PrinoPharma — PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
- SenseTime — SenseTime Medical is an AI healthcare firm that creates solutions for hospitals, research institutions, and the global medical market. Through its SenseCare platform, the company provides over 40 specialized AI modules and maintains strategic partnerships with organizations like Roche, Midea, and Ruijin Hospital to streamline patient services andmedical innovation.
- Falcon Technology — Falcon Technology focuses on DSA processor design innovation, developing a dedicated computing technology ecosystem based on the RISC-V architecture to deliver high-performance, energy-efficient processing solutions for next-generation intelligent computing applications.
Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: China, United States, Singapore
Investor stats
- Total investments: 216
- Round size: Seed $1.9M–$14M; Series A $1.4M–$43M; Series B $8M–$145M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Sondit — Sondit specializes in R&D and manufacturing of civilian radar systems. It includes intelligent transportation, intelligent security, vehicle-road coordination, and other fields. It engaged in traffic information monitoring and urban traffic management in the field of the intelligent transportation industry.
- Fastlane — We take innovative brands global. Fastlane is a full-service D2C solutions provider that assists enterprises with brand development, business infrastructure, and sales creation/growth in European, North American and Asian markets. We offer a superior one-stop solution, with expertise in go-to-market strategy, traditional and digital marketing,PR, logistics, e-commerce, sales, and platform development. We work with companies big and small, and our custom-tailored solutions range in scope from basic consulting services to 360° turnkey operations.
- Automation Hero — Reduce your company's document processing time with an intelligent automation platform that's simple, secure, and accurate.
Lenovo Capital and Incubator Group is an accelerator and venture capital firm.
Show more...Investment focus
- Industry: Manufacturing, Artificial Intelligence, Software
- Stage:Series A, Seed, Series B
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 265
- Round size: Seed $1.5M–$42M; Series A $2.8M–$73M; Series B $5.5M–$150M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $500M in 2016
Portfolio highlights
- Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
- SenseTime Medical — SenseTime Medical promotes the development and implementation of its medical big model and provides smart health solutions.
- Shenzhen Urban Transport planning Center — Shenzhen Urban Transport planning Center provides traffic information engineering and technical services in China.
Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.
Show more...Investment focus
- Industry: Manufacturing, Semiconductor, Medical
- Stage:Series A, Series B, Seed
- Geography: China, United States
Investor stats
- Total investments: 37
- Round size: Series A $1.4M–$70M; Series B $11M–$142M
- Lead/follow: 49% lead, 51% follow
Portfolio highlights
- Teyan Semiconductor — Taiyan Semiconductor is a semiconductor process and equipment service provider in the field of advanced packaging. It provides customers with advanced packaging production lines such as SiP, Fanout, Chiplet, 3D, etc. Laser (laser) + Plasma (plasma) + Sputter (coating) complete composite process and Process application equipment.
- Ruimeng Semiconductor — Ruimeng Semiconductor is a provider of intelligent human-machine interface processor chips and solutions.
- Baisheng Smart Computing — Baisheng Smart Computing specializes in the field of information technology application innovation, operations, and maintenance.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Series A, Series B, Seed
- Geography: China, Singapore, Norway
Investor stats
- Total investments: 74
- Round size: Seed $10M–$120M; Series A $10M–$85M; Series B $14M–$99M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Yatsen Holding — Yasten provides high-quality fashion makeup products.
- RoboticPlus.AI — RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
- Unbounded Dynamics — Unbounded Dynamics is a robotics and embodied intelligence startup focused on developing foundational AI “brains” and operational intelligence for robots and autonomous systems aimed at industrial and B-end scenarios. It works on the coordination of perception (“eyes”), manipulation (“hands”), and decision-making (“brain”) in physical robots bybuilding general basic models and expert system integrations as part of a hardware-software architecture to enable continuous iterative evolution of embodied intelligence.
MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Angel, Pre-Seed
- Geography: China, United States, Singapore
Investor stats
- Total investments: 76
- Lead/follow: no public data
Portfolio highlights
- TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
- Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
- Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
ULTIMA is an investment management firm.
Show more...Investment focus
- Industry: Hardware, Software, Agriculture
- Stage:Angel, Series A
- Geography: China
Investor stats
- Total investments: 4
- Round size: Series A $1.6M–$15M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, South Korea
Investor stats
- Total investments: 243
- Round size: Seed $1.3M–$100M; Series A $4.3M–$52M; Series B $11M–$62M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — raised $375M in 2021
Portfolio highlights
- Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
- Moge Microflow — Moge Microflow is a manufacturer of equipment for microreactors. It provides continuous flow production technologies and equipment for nanomaterials, pharmaceutical intermediates, and fine chemicals, as well as standardized high-end microreactor equipment.
- Bianzhong New Materials — Bianzhong New Materials is a high-tech company that specializes in the research and development of equipment for weaving and shaping three-dimensional preforms of high-strength fiber composite materials.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States
Investor stats
- Total investments: 70
- Round size: Seed $1.4M–$15M; Series A $1.4M–$32M; Series B $7.1M–$34M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Genlight — Genlight develops innovative treatment solutions for epilepsy and other neurological diseases. Genlight is headquartered in Hangzhou, China.
- Pipi Bear —
- Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more...Investment focus
- Industry: Manufacturing, Medical, Health Care
- Stage:Series A, Seed, Series B
- Geography: China, United States, India
Investor stats
- Total investments: 141
- Round size: Seed $1.4M–$4M; Series A $1.4M–$16M; Series B $2.8M–$85M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Tpson — Tpson is a Smart Hardware company.
- Ounuo Semiconductor — Ounuo Semiconductor is a manufacturing company that provides research and development of semiconductor equipment.
- HUAXI Technology — HUAXI Technology is a global leader specializing in the development and delivery of comprehensive, high-end smart elderly care solutions. By integrating advanced technologies such as the Internet of Things (IoT), artificial intelligence (AI), and big data analytics, the company is dedicated to enhancing the quality of life for seniors worldwide.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 168
- Round size: Seed $7.1M–$41M; Series A $3.8M–$47M; Series B $3M–$73M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Dami&Xiaomi — Rice and millet is China's leading platform services for children with autism spectrum, from 2014 Nian 9 Yue Jiang Ying Shuang (rice) founded the "rice and millet" micro-channel public number. It now provides integrated services such as rehabilitation services, integrated education support, parent training, online courses, andpopular science information.
- CART Medical — CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory.
- MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: China, India, Canada
Investor stats
- Total investments: 139
- Round size: Seed $450k–$5M; Series A $2.8M–$17M; Series B $2.8M–$47M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Kongshanci — Kongshanci specializes in non-invasive brain-computer interfaces and neuromodulation.
- PowerMicro — PowerMicro focuses on the cutting-edge interdisciplinary field of “stem cells + engineered scaffolds,” specializing in the application of iPSC technology to advance regenerative medicine, tissue engineering, and innovative therapeutic solutions.
- Baiyao Technology — Baiyao Technology is a biopharmaceuticals company offering drug and treatment plan development utilizing AI simulation of life processes.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: China, United States, South Korea
Investor stats
- Total investments: 408
- Round size: Series A $2.9M–$93M; Series B $12M–$115M; Series C $14M–$156M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $177M in 2021
Portfolio highlights
- Pony.ai — Pony.ai is a startup that builds full-stack autonomous driving solutions. It is a pioneer in autonomous mobility technologies and services across the US and China, spearheading public-facing Robotaxi pilots in both markets. Pony.ai is committed to creating a safe and sustainable mobility future by delivering autonomous mobility everywhere.Thecompany was founded by James Peng and Tiancheng Lou in 2016 and is headquartered in Fremont, California, United States.
- Lunit — With AI, we aim to make data-driven medicine the new standard of care. We are especially focused on conquering cancer, one of the leading causes of death worldwide.
- CMind-SEMI — CMind is committed to becoming the new global leader in smartphone communication chips by concentrating on 4G and 5G advanced wireless communication chips and complete solutions.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 45
- Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$40M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $250M in 2015
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.
Show more...Investment focus
- Industry: Manufacturing, Software, Enterprise
- Stage:Series A, Angel
- Geography: China
Investor stats
- Total investments: 24
- Round size: Series A $222k–$27M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Songying Technology — Songying Technology focuses on the research and development of cloud-native real-time 3D engines and graphics collaboration platforms.
- Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
- Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Tianjin Venture Capital is an investment firm.
Show more...Investment focus
- Industry: Manufacturing, Information Technology, Biotechnology
- Stage:Seed, Series A
- Geography: China, United States
Investor stats
- Total investments: 106
- Round size: Seed $413k–$15M; Series A $202k–$31M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
- Xingneng Xuanguang — Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology.
- Innovec Biotherapeutics — Innovec Biotherapeutics Specialized in gene therapy technology and medication development.
CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.
Show more...Investment focus
- Industry: Manufacturing, Health Care, E-Commerce
- Stage:Series A, Series B, Series C
- Geography: China, United States, Japan
Investor stats
- Total investments: 101
- Round size: Series A $3M–$230M; Series B $2.8M–$50M; Series C $10M–$220M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $2.8B in 2018
Portfolio highlights
- YQN — YQNLink specializes in digital logistics, providing a comprehensive suite of international logistics services. This includes sea freight, air freight, rail freight, and multimodal transportation solutions. With a focus on leveraging digital technology, YQNLink aims to enhance supply chain transparency and efficiency, making shipping processessimpler for businesses. The company offers consultative services to tailor logistics solutions to specific business needs, ensuring a streamlined and effective logistics strategy. YQNLink's acquisition of COPE, a cross-border e-commerce logistics firm, further expands its capabilities in serving the e-commerce sector.
- NEON — Discover a global experience entertainment company specialising in unique, immersive and large-scale experiences held all around the world, all year round.
- Neolix — Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc.
Jinqiu Fund invests in biotechnology companies
Show more...Investment focus
- Industry: Artificial Intelligence, Robotics, Manufacturing
- Stage:Seed, Series A, Angel
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 35
- Lead/follow: no public data
Portfolio highlights
- MindOn — MindOn is a robotics company that develops artificial intelligence software and algorithms to create humanoid robots.
- Miracle Rabbi — MiracleRabi is an AI-powered trendsetting brand focused on the research, development, and promotion of AI toys, integrating cutting-edge artificial intelligence, interactive technologies, and imaginative design to create engaging, educational, and emotionally intelligent play experiences that inspire creativity and redefine the future of smartentertainment.
- Qingxian Intelligence — Qingxian Intelligence is a smart office and home office technology company. The company focuses on smart, comfortable, and healthy office scenarios.
Sunz Fund is a venture capital firm that focuses on investments in life science, medical health and resources environment sectors.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Series A, Seed, Series B
- Geography: China
Investor stats
- Total investments: 22
- Round size: Seed $1.4M–$7.4M; Series A $1.4M–$14M; Series B $2.8M–$2.8M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Heproa — Heproa is a dermatological-grade skin care brand. It adheres to the new concept of micro-ecological scientific research and skin care.
- Infineon Multiomics — Infineon Multiomics is a biotechnology company that provides research and application of space multiomics technology.
- Casibrain Technology — Casibrain Technology is a medical device enterprise that has grown up from the Institute of Automation.
Tsinghua Capital is an investment firm.
Show more...Investment focus
- Industry: Manufacturing, Artificial Intelligence, Biotechnology
- Stage:Seed, Angel, Series A
- Geography: China, Australia
Investor stats
- Total investments: 74
- Round size: Seed $1.4M–$73M; Angel $425k–$14M; Series A $2.3M–$17M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
- Qinghao Puzhong — Qinghao Puzhong is a technological development and manufacturing company that produces resin-infiltrated ceramic-based dental restoration materials.
- Zhiyuan Shenlan — Zhiyuan Shenlan focuses on data-driven biomolecule design and manufacturing.
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Series B, Seed
- Geography: China, United States
Investor stats
- Total investments: 246
- Round size: Seed $2.9M–$74M; Series A $1.4M–$43M; Series B $2.9M–$100M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- VAST — VAST is an artificial intelligence business that develops and manufactures general-purpose 3D big models. Its goal is to develop a popular 3D content production tool, a 3D user-generated content platform, and utilize 3D space to enhance user experience.
- Kongshanci — Kongshanci specializes in non-invasive brain-computer interfaces and neuromodulation.
- Lightwheel — Light Wheel Intelligence is offers automated, physically precise and controllable, real and generalizable synthetic data solutions to build AI data infrastructure,
Our team invests in early-stage digital health and consumer startups at CentreGold Capital.
Show more...Investment focus
- Industry: Medical Device, Internet, Health Care
- Stage:Seed, Series A, Angel
- Geography: United States, China, Canada
Investor stats
- Total investments: 17
- Round size: Seed $567k–$3M; Series A $1.8M–$12M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
- Virgo — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
- WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.
Haitang Fund is a venture capital fund jointly established by Tianjin University alumni entrepreneurs and other alumni and entrepreneurs.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: China
Investor stats
- Total investments: 44
- Round size: Seed $7.1M–$15M; Series A $213k–$14M; Venture - Series Unknown $14M–$44M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- DMS — Founded in 2002, DMS is a premier provider of industrial AI digital foundations and smart plant solutions. With over two decades of deep-rooted expertise in the process industry, we are pioneering a new era of digital transformation through our core philosophy: "AI IN ALL, ALL ON ONE." We deliver a unified, AI Agent-driven digital basethat integrates complex data into actionable intelligence. By bridging the gap between engineering technology (ET), information technology (IT), and operational technology (OT), DMS empowers global enterprises to achieve unprecedented levels of efficiency, safety, and sustainability. DMS specializes in Asset Lifecycle Information Management (ALIM). Our solutions provide a seamless digital thread that spans the entire asset journey: from design, procurement, construction, commissioning, handover, to operations and maintenance. DMS solutions is engineered to meet and exceed international standards (ISO 15926, CFIHOS). It has been rigorously validated by industry leaders as a comprehensive, high-performance alternative to legacy systems. We offer superior data interoperability, a more agile low-code environment, and a significantly lower total cost of ownership (TCO) without compromising on industrial-grade robustness.
- OakDeer Robotics — OakDeer Robotics is a robotics company that specializes in the development of smart cooking machines to make food processing more efficient. It is a subsidiary of Oak Heron Technology.
- Plastic New Technology — Suxin Technology focuses on the enzymatic depolymerization and recycling of post-consumer waste polyester textiles and other polymeric materials.
Lucion is an influential professional venture capital institute.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Medical
- Stage:Series A, Series B
- Geography: China
Investor stats
- Total investments: 56
- Round size: Series A $1.4M–$539M; Series B $2.8M–$144M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Robot Era — Robot era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products. Xingdong Era is committed to the development of universal humanoid robots that can adapt to a wide range of fields, multiple scenarios, and high intelligence, striving to realize the beautiful vision of intelligent robotsentering thousands of households and integrating into the lights of thousands of homes.
- Oricell Therapeutics — OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.
- Wutong Sensing Control — Wutong Sensing Control is a leading company that specializes in the research, development, and innovation of cutting-edge robotic mechanics and tactile sensing technologies. With a strong focus on advancing automation systems, the company aims to enhance the precision, efficiency, and adaptability of robotic applications in various industries,including manufacturing, healthcare, and consumer electronics.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Innoangel Fund is an investment firm that invests in early stage companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Robotics, Manufacturing
- Stage:Angel, Seed, Series A
- Geography: China, Canada, Hong Kong
Investor stats
- Total investments: 216
- Round size: Seed $425k–$27M; Angel $425k–$14M; Series A $1.4M–$14M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- InfinAstro — InfinAstro is a firm that develops and manufactures rocket engines, rocket launch equipment, rocket control systems, and microsatellites.
- Zhidao Hechuang — Zhidao Hechuang is a comprehensive solution provider for new energy asset management.
- Zhiyuan Shenlan — Zhiyuan Shenlan focuses on data-driven biomolecule design and manufacturing.
Shangshi Fund is an investment firm.
Show more...Investment focus
- Industry: Information Technology, Manufacturing, Artificial Intelligence
- Stage:Series A, Angel, Seed
- Geography: China
Investor stats
- Total investments: 62
- Round size: Seed $1.4M–$73M; Angel $283k–$2.1M; Series A $1.4M–$71M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Approaching.AI — Approaching.AI is an AI Infra company focusing on the important large model application scenarios such as RAG.
- Qianjue Technology — Qianjue Technology is a company that created the first full-stack application-level robot model and offers cloud-based artificial intelligence solutions to robot manufacturers.
- Optical Interconnect Technology —
Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Japan
Investor stats
- Total investments: 34
- Round size: Series A $10M–$227M; Series B $18M–$102M; Series C $23M–$71M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Sniper Medical Technology — Sniper develops accurate and intelligent molecular diagnostic solutions. Taking the next-generation fully automatic digital PCR as a breakthrough, the company has developed a droplet generation method with global independent intellectual property rights - Vibrant Injection technology and created a new path of chip-free droplet generationtechnology. It solves the pain points of high cost and complicated operation of microfluidic technology in practical application and is expected to bring subversive innovation in the field of refined medical testing.
- Osteal Therapeutics — Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
- Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
BMC engaged in asset management, investment management and consulting.
Show more...Investment focus
- Industry: Biotechnology, Medical, Product Research
- Stage:Seed, Series B
- Geography: China
Investor stats
- Total investments: 12
- Round size: Seed $1.4M–$14M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- OneTar Biomedicine — OneTar Biomedicine is a biopharma company that develops organoid and oncology drugs.
- Fuan Green Energy Technology — Fuan Green Energy Technology focuses on the research and development of new battery technologies, aiming to improve the energy density and safety of energy storage systems.
- Jingyao Xinhui Semiconductor — Jingyao Xinhui Semiconductor is the indium phosphide optical chip manufacturer company.
Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States, Czech Republic
Investor stats
- Total investments: 64
- Lead/follow: no public data
Portfolio highlights
- Sofía — Improving the way millions of people take care of their health
- Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Yida China Holdings provides park development, park operation, construction, property management, landscaping, and decoration services. Their customers inquiries are addressed through phone, email, and online applications.
Show more...Investment focus
- Industry: Manufacturing, Semiconductor, Biotechnology
- Stage:Series A, Series B
- Geography: China, United States
Investor stats
- Total investments: 19
- Lead/follow: no public data
Portfolio highlights
- Sizone Technology — Sizone Technology is a chemical mechanical planarization (CMP) equipment company providing services to the semiconductor industry.
- Alit Life Sciences — Alit positioned as a supplier of instruments, equipment and technical services in the life science and biotechnology industries, the company has developed several series of products from Biotech, Altair, Rigel and Mira after launching its self-developed Countstar IC1000 cell analyzer in 2011.
- General Biosystems — General Biosystems is a biotechnology company that focuses on high-quality, high-throughput, automated production of DNA constructs. The company through its passion in understanding how genetic information is stored and programmed in the DNA develops innovative technologies and instruments to program and physically write or print new genetic codes.The new codes will create blueprints for new or enhanced biological and biological functions.
Ruijiang Investment is a market-oriented, professional and international fund management company focusing on equity investment funds, industrial investment funds and asset management business, with a management scale of more than 2 billion yuan.
Show more...Investment focus
- Industry: Medical, Biotechnology, Electronics
- Stage:Seed, Series A, Series C
- Geography: China
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- Tuo Rui Jing — Tuo Rui Jing is a global molecular diagnostic company with technological innovation at its core.
- Ruixun Biotech — Ruixun Biotech is a Healthcare company.
- Qianjue Technology — Qianjue Technology is a company that created the first full-stack application-level robot model and offers cloud-based artificial intelligence solutions to robot manufacturers.
Starlight Capital provides investment and assistance to companies from the digital industry. It searches for businesses that are focusing on digital transformation and helps with its management. Starlight Capital is based in Shanghai, China.
Show more...Investment focus
- Industry: Manufacturing, Robotics, Information Technology
- Stage:Series A, Series C, Series B
- Geography: China
Investor stats
- Total investments: 17
- Round size: Series A $14M–$27M; Series B $2M–$55M; Series C $14M–$31M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- DeepDataSpace — DeepDataSpace is a visual large-scale model company incubated by IDEA Research Institute.
- Hailan Acoustics — Hailan Acoustics focuses on the research and development, production and sales of marine sensors and equipment.
- Zhongjian Technology — Zhongjian Technology provides computers, telecommunication, and other electronic devices.
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: China, United States, Canada
Investor stats
- Total investments: 263
- Round size: Series A $8.3M–$198M; Series B $14M–$142M; Series C $14M–$300M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Changmugu Medical — Changmugu Medicalis an artificial intelligence (AI)-powered healthcare start-up providing AI-powered surgical robot solutions.
- ReviR Therapeutics — ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
- Jinfang Pharmaceutical — Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.
Danen Ventures is an early-stage venture capital firm that focuses on high-growth fields, such as information technology and internet, renewable energy and environmental, advanced manufacturing industry, biotechnology and medical science, and healthcare.
Show more...Investment focus
- Industry: B2B, Fashion, Medical
- Stage:Series A, Angel, Seed
- Geography: China, United States
Investor stats
- Total investments: 10
- Round size: Angel $1.4M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CartaBio — CartaBio is an authorised spatial omics technology platform. CartaBio specializes in the creation of AI-integrated solutions for the biotech industry, including scission-accelerated fluorophore exchange and the multimodal CellBERT model.
- SynMetaBio — SynMetaBio is a company that develops synthetic biological materials, combining synthetic biology and material design. Their business modules include bio-based medical beauty, functional recombinant proteins, and medical aesthetic materials, including bionic bio-based leather.
- Meiyou Technology — Meiyou Technology is a DNA synthesizer developer focusing on enzymatic long-fragment DNA synthesis and splicing technology. They use high-throughput synthesizers to reduce DNA synthesis costs and offer gene design services for the biotechnology industry.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more...Investment focus
- Industry: Health Care, Medical, Manufacturing
- Stage:Series A, Series B, Seed
- Geography: China, United Kingdom, United States
Investor stats
- Total investments: 230
- Round size: Seed $1.4M–$29M; Series A $1.4M–$42M; Series B $2.8M–$103M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Tinychip — Tinychip is a microelectronics chip company that manufactures analog-to-digital hybrid automotive chips.
- MindMotion — MindMotion is an electronics company that supplies general-purpose 32-bit MCU products and solutions. The company's MM32 MCU products developed by the company based on the Arm Cortex-M series cores have four series of F/L/SPIN/W, more than 200 models, and a cumulative delivery of more than 300 million units, ranking in theforefront of local general-purpose 32-bit MCU companies.MindMotion was founded in 2011 and is headquartered in Shanghai, China.
- Nuoyun Drive —
Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: China, Singapore, United States
Investor stats
- Total investments: 47
- Round size: Series A $2.8M–$14M; Series B $13M–$61M; Series C $15M–$100M
- Lead/follow: 49% lead, 51% follow
Portfolio highlights
- Aires — Aires is a high-tech enterprise specializing in the research, development, manufacturing, and sales of contact lenses, dedicated to delivering high-quality vision care products through advanced lens technology, strict quality standards, and innovative designs that ensure comfort, safety, and clear vision for consumers.
- Ruize Health — Ruize Health is a commercial insurance company that focuses on health consumption and commercial insurance.
- Accro Bioscience — Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.
BOHE Angel Fund is an investment Fund.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Angel, Seed, Series A
- Geography: China
Investor stats
- Total investments: 16
- Round size: Seed $14M–$15M; Angel $1.4M–$100M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- KangaBio — KangaBio is a biotech business specializing in developing novel medicines to meet unmet medical needs. It helps in developing prodrugs of immune-stimulating medicines and other multi-specific biologics to minimize toxicities and boost treatment efficacy for already established targets.
- PrinoPharma — PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
- Qinhao Pharmaceutical — Qinhao Pharmaceutical is harmaceutical enterprises with a gathering of humanities and innovation.
Orient Securities Capital Investment is an private equity fund business platform.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Software
- Stage:Series A, Series B, Series D
- Geography: China
Investor stats
- Total investments: 39
- Round size: Series A $1.4M–$73M; Series B $1.4M–$100M; Series D $51M–$71M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- AutoAgents — AutoAgents is committed to offering software services for intelligent assistants (Copilot) and autonomous agents (AI Agents) through AI.
- Yushi Space — Yushi Space is a liquid rocket developer that focuses on the development and manufacture of large-capacity, low-cost and rapidly reusable liquid rockets.
- Blackflame Medical — BlackFlame Medical develops proprietary 3D printing technology, software, and materials specifically for the healthcare sector. By collaborating directly with doctors, they create personalized digital solutions for surgery and rehabilitation, driving medical innovation through customized patient care.
Zoo Capital is focusing on early-stage investments in technology, healthcare, and consumer companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 23
- Round size: Seed $3.2M–$14M; Series A $15M–$100M; Series B $90M–$100M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Bio-Link — Bio-Link is a drug development company that offers solutions for the life science industry. Bio-Link was founded in 2001 and was headquartered in Shanghai, China.
- Future Intelligence — Vision Intelligence is a AI smart hardware company that manufactures and sells interactive intelligence based electronic consumer products.
- LTZ Therapeutics — LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
K2VC (Xianfeng Evergreen) was founded in 2010, focused on early stage investment in technology start-ups in China, focus on promoting change and technological progress, innovative business models and lifestyles.
Show more...Investment focus
- Industry: E-Commerce, Manufacturing, Biotechnology
- Stage:Series A, Seed, Angel
- Geography: China, United States, Japan
Investor stats
- Total investments: 190
- Round size: Seed $1M–$14M; Angel $425k–$10M; Series A $1.4M–$25M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $141M in 2018
Portfolio highlights
- YolTech Therapeutics — Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, andinnovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.
- Senyue Chengxing —
- Mofeng Technology — Mofeng Technology is a high-tech enterprise specializing in the research and development of polymer materials.
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: China, United States, Singapore
Investor stats
- Total investments: 454
- Round size: Seed $1.4M–$32M; Series A $2.9M–$57M; Series B $10M–$113M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Lexin — LexinFintech Holdings is an online consumer finance platform for educated young adults in China. As one of China's leading financial technology companies, Lexin integrates its e-commerce-driven installment finance platform, Fenqile, with advanced risk management technologies, the Company's Dingsheng online investment platform, and theCompany's Juzi Licai online investment platform for individual investors, to create a comprehensive consumer finance ecosystem. The Company utilizes technologies including big data, cloud computing and artificial intelligence to enable the near-instantaneous matching of user funding requests with offers from the Company's more than 30 funding partners, which include commercial banks, consumer finance companies, and other licensed financial institutions. By serving the credit needs of China's educated young adults, Lexin helps its more than 20 million registered users to enjoy a better quality of life through the use of better credit.
- Liepin — Liepin is the largest and most professional high-end talent community-based recruitment site, with its innovative products and unique service model model for create an interactive high-end talent recruitment platform between business, headhunting and workplace. Tens of thousands of professional executive search consultant for businesses and jobseekers set up communication between the bridge and accelerate corporate recruitment process, recommended paying jobs in the workplace, career development planning. 16 job seekers to avoid the risk of privacy protection, millions of high-end elite member libraries, help enterprises development needs.
- VOMMA — VOMMA is a light field camera 3D machine inspection solution provider.
Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: United States, China, India
Investor stats
- Total investments: 365
- Round size: Series A $6.4M–$62M; Series B $8.5M–$80M; Series C $14M–$115M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $350M in 2022
Portfolio highlights
- GoodData.AI — GoodData is a leading composable data and analytics platform. Build, embed, and scale analytics on demand, with zero vendor lock-in.
- Fuse Universal — Fuse is the learning platform that allows your people to connect with the knowledge and expertise they need to improve their skills and perform.
- Lighthouse — Lighthouse transforms complexity into confidence with actionable insights, business intelligence & pricing solutions that maximize revenue.
Loyal Valley Capital is a thematic, research-driven private equity firm.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series C, Series A, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 103
- Round size: Series A $2.7M–$170M; Series B $25M–$145M; Series C $29M–$300M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $465M in 2019
Portfolio highlights
- YolTech Therapeutics — Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, andinnovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.
- Surgerii Technology — Beijing Surrey is a technology company founded by an industry elite active in China's medical equipment. Relying on the core technology of the new generation of flexible continuum robotic arm, running through the implementation paradigm of many types of clinical minimally invasive surgery, and harnessing the powerful system design andintegration capabilities, Beijing Shurui is committed to becoming the first independent independent research and development, production and sales in China.
- Microtide Biotechnology — Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine.
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Kenya
Investor stats
- Total investments: 100
- Round size: Series A $2.8M–$50M; Series B $15M–$100M; Series C $12M–$156M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Yosemite Clinic — Yosemite Clinic is a full-service clinic providing convenient walk-in medical services in a state-of-the-art environment in Central Pudong. They offer family medicine, internal medicine, surgery, orthopedics (sports medicine), dermatology, medical cosmetology, dentistry, gynecology, pediatrics, ophthalmology, anesthesiology, rehabilitationmedicine, medical imaging, laboratory, pharmacy and more. Their onsite facilities and equipment include CT, X-ray, Ultrasound, Laboratory and Operating Rooms. Their doctors come from China and across the world, enabling us to serve you in many languages including, English, Japanese, Malay, Mandarin Chinese and Cantonese.
- Archimedes Vascular — Archimedes Vascular operates as a medical device company, that treat patients with severe hypertension.
- Biortus — Wuxi Biortus Biosciences is an innovation-driven contract research organization (CRO) committed to high-quality R&D services in support of drug discovery.To help our clients achieve their drug discovery goals, we have established five world-class research platforms. These are Recombinant Protein Production, Structural Biology (X-rayCrystallography and Cryo-EM), In Vitro Assays and Screening, Medicinal Chemistry, and Process Development. Through the years, our R&D team has developed a number of practical and innovative techniques of which some have already been granted patent.
Life Science Investor funding in China at a glance
Stats across 304 deals from 570 investors.
Access all 570 investors in China Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in China investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 570 investors investing in China Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!